Department of Endocrinology, Medical School, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Clin Biochem. 2010 Nov;43(16-17):1333-9. doi: 10.1016/j.clinbiochem.2010.08.019. Epub 2010 Aug 25.
To find whether polymorphisms of methylenetetrahydrofolate reductase (MTHFR) C677T and A1298C are risk factors for diabetic nephropathy (DN) among type 2 diabetes mellitus (T2DM) patients from Western Iran.
The MTHFR polymorphisms were detected in 72 microalbuminuric, 68 macroalbuminuric and 72 normoalbuinuric T2DM patients by PCR-RFLP.
The possession of both MTHFR 677T and 1298C alleles increase the risk of microalbuminuria to 4.3-fold (p=0.007) in T2DM patients. The presence of either MTHFR 677T, 1298C allele is sufficient to increase the risk of macroalbuminuria in T2DM patients by 4.1 and 5.5 times (p=0.027, and p=0.006, respectively). The concomitant presence of both 677T and 1298C alleles act in synergy to increase the risk of macroalbuminuria by 20.4-fold (p<0.001) and progression of DN from microalbuminuria to macroalbuminuria (OR=4.73, p=0.01).
Both MTHFR 677T and 1298C alleles increased the susceptibility to the onset and progression of DN in Iranians with T2DM.
在来自伊朗西部的 2 型糖尿病(T2DM)患者中,寻找亚甲基四氢叶酸还原酶(MTHFR)C677T 和 A1298C 多态性是否为糖尿病肾病(DN)的危险因素。
通过 PCR-RFLP 检测 72 例微量白蛋白尿、68 例大量白蛋白尿和 72 例正常白蛋白尿的 T2DM 患者的 MTHFR 多态性。
同时携带 MTHFR 677T 和 1298C 等位基因会使 T2DM 患者发生微量白蛋白尿的风险增加 4.3 倍(p=0.007)。仅携带 MTHFR 677T、1298C 等位基因就足以使 T2DM 患者发生大量白蛋白尿的风险分别增加 4.1 倍和 5.5 倍(p=0.027 和 p=0.006)。同时携带这两个等位基因的协同作用会使大量白蛋白尿的风险增加 20.4 倍(p<0.001),并且使从微量白蛋白尿到大量白蛋白尿的 DN 进展风险增加 4.73 倍(p=0.01)。
MTHFR 677T 和 1298C 等位基因均会增加伊朗 T2DM 患者发生 DN 的易感性和进展。